CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- SC 13G/A Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- EFFECT Other Notice of Effectiveness
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise Director acquired 513 shares (option exercise)
- 4 Open-market buy Director bought 1,000 shares at $14.38 ($14,381)
- 4 Option exercise Director acquired 3,702 shares (option exercise)
- 4 Option exercise President and CEO acquired 7,000 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise President and CEO acquired 34,167 shares (option exercise)
- ARS Other Annual Report to Security Holders
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,000 shares at $12.46 ($12,460)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 41 of 68 · 1,358 filings